World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: CTRI
Last refreshed on: 24 November 2021
Main ID:  CTRI/2015/07/005960
Date of registration: 03-07-2015
Prospective Registration: No
Primary sponsor: Aravind Eye care System
Public title: To compare which type of sugery is better for treatment of pterygium
Scientific title: Comparative outcome of Conjunctival autograft and Amniotic membrane transplantation following double pterygium excision in the same eye
Date of first enrolment: 05-04-2011
Target sample size: 31
Recruitment status: Completed
URL:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10669
Study type:  Interventional
Study design:  Randomized, Parallel Group, Active Controlled Trial
Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:On-site computer system Blinding and masking:Participant, Investigator and Outcome Assessor Blinded
 
Phase:  N/A
Countries of recruitment
India
Contacts
Name: Venkatesh Prajna   
Address:  1,Anna Nagar,Aravind eye hospital,Madurai,Tamil Nadu,India 1,Anna nagar,Aravind eye hospital. 625020 Madurai, TAMIL NADU India
Telephone: 04524356550
Email: prajna@aravind.org
Affiliation:  Aravind eye hospital
Name: Venkatesh Prajna   
Address:  1,Anna Nagar,Aravind eye hospital,Madurai,Tamil Nadu,India 1,Anna nagar,Aravind eye hospital. 625020 Madurai, TAMIL NADU India
Telephone: 04524356550
Email: prajna@aravind.org
Affiliation:  Aravind eye hospital
Key inclusion & exclusion criteria
Inclusion criteria: age more than 18 years

primary double pterygium with operable features

Exclusion criteria: children below the age of 18 years

previous history of trauma or chemical injury

pregnancy


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Health Condition 1: null- Double pterygium
Intervention(s)
Control Intervention1: conjunctival autograft: The tissue which is taken from patients own superior bulbar conjunctiva and tranplanted at the excised site
Control Intervention2: amniotic membrane graft: Tissue which is prepared from human placenta and processed and preserved placed at the excision site.Since this is not a drug there is no dosage schedule and its done only once.
Primary Outcome(s)
To assess the recuurence of pterygium nasally and temporally after double pterygium excision when replaced with conjunctival autograft and amniotic graft randomlyTimepoint: 0-1 year
Secondary Outcome(s)
To assess whether site of replacement of the conjunctival autograft and amniotic membrane graft plays a role in recurrenceTimepoint: 0-1 year
Secondary ID(s)
NIL
Source(s) of Monetary Support
Self funded
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 25/03/2011
Contact:
Aravind eye care system intitutional review board
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history